A Study of Dapansutrile Plus Pembrolizumab in Patients With PD-1 Refractory Advanced Melanoma
Clinical trial NCT04971499 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT04971499
- Sponsor
- April Salama, M.D.
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-09-06
- Primary completion
- 2027-04-30
- Enrollment
- 26
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.